Guardian -- The pharmaceuticals industry needs to rebuild its image with a public sceptical of science and genetically modified crops, and at Germany’s Bayer group they are trying to do just that.
Guardian -- The pharmaceuticals industry needs to rebuild its image with a public sceptical of science and genetically modified crops, and at Germany’s Bayer group they are trying to do just that.
